NITISH MEHTA

NEW YORK, NY

This page merges CMS profile IDs: 5704833, 7233301 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$17,415.70

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 73
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $6,128.58 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $5,470.003
Food and Beverage $658.589

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $407.274
2019 $751.342
2020 $23.641
2021 $7,094.6533
2022 $609.9512
2023 $2,400.279
2024 $6,128.5812

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089507960 EyePoint Pharmaceuticals US, Inc. $115.04 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089508078 EyePoint Pharmaceuticals US, Inc. $1,850.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114402601 Regeneron Pharmaceuticals, Inc. $125.35 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114402603 Regeneron Pharmaceuticals, Inc. $43.60 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114402605 Regeneron Pharmaceuticals, Inc. $70.51 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114402607 Regeneron Pharmaceuticals, Inc. $1,448.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114402609 Regeneron Pharmaceuticals, Inc. $2,172.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1140421503 Bausch & Lomb Americas Inc. $111.33 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148202239 Ocular Therapeutix, Inc. $30.62 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154027289 Apellis Pharmaceuticals, Inc. $90.38 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154027291 Apellis Pharmaceuticals, Inc. $25.45 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154027293 Apellis Pharmaceuticals, Inc. $46.30 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 5704833, 7233301

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.